期刊文献+

加强妊娠合并心脏病多学科协作治疗模式管理,降低孕产妇死亡率 被引量:36

MDT management in pregnancy complicated with heart diseases to reduce maternal mortality
原文传递
导出
摘要 孕产妇死亡是指任何妊娠或妊娠相关的原因导致孕产妇从开始妊娠至产后42d内出现死亡(意外死亡的孕产妇不包括在内)。孕产妇死亡率是反映一个区域政治、经济、文化和卫生状况的重要指标。随着医疗技术水平的提高,国家卫生健康委员会发布《中国妇幼健康事业发展报告(2019)》,提示2018年全国孕产妇死亡率下降至18.3/10万。
作者 林建华 缪慧娴 LIN Jian-hua;MIAO Hui-xian
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2019年第11期1185-1188,共4页 Chinese Journal of Practical Gynecology and Obstetrics
基金 国家科技部“十二五”支撑计划项目(2014BAI05B05)
关键词 妊娠 心脏病 多学科协作治疗模式 pregnancy heart disease multi-disciplinary team
  • 相关文献

参考文献3

二级参考文献32

  • 1Evangelista A, Avegliano G, Aguilar R, et al. Impact of contrast-enhanced echocardiography on the diagnostic algorithm of acute aortic dissection[J]. Eur Heart J, 2010,31(4): 472-479.
  • 2ACOG Committee on Obstetric Praetiee. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy[J]. Obstet Gynecol, 2004, 1 04(3):647-651.
  • 3Kampman MA, Balei A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretie peptide predicts cardiovascular complications in pregnant women with congenital heart disease [J]. Eur Heart J, 2014,35(11):708-715.
  • 4European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [J]. Eur Heart J. 2011,32(24):3147-3197.
  • 5Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease[J]. Circulation, 2001,104(5):515-521.
  • 6Drenthen W, Boersma E, Balei A, et al. Predictors of pregnancy complications in women with congenital heart disease[J]. Eur Heart J, 2010,31(17):2124-2132.
  • 7Hurst JW. The value of using the entire New York Heart Association' s classificationof heart and vascular disease[J]. Clin C ardiol, 2006, 29(9):415-417.
  • 8Mukoyama M, Nakao K, Hosodo K, et al. Brain natriureticpeptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest, 1991, 87(4):1402-1412.
  • 9Kim SW, Park SW, Lira SH, et al. Amount of left ventrieular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction [J]. Clin Cardiol, 2006,29(4):155-160.
  • 10Gali N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [J]. Eur Heart J, 2009,30(20):2493-2537.

共引文献233

同被引文献304

引证文献36

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部